Cargando…

Phylodynamic Analysis and Implication of HCV Genotype 4 Variability on Antiviral Drug Response and T-Cell Recognition

Therapies for HCV care could change the prevalence and the geographic distribution of genotypes due to differences in Sustained Virologic Response (SVR). In this scenario, uncommon genotypes/subtypes, such as genotype 4, could spread from high-risk groups, replacing genotypes eradicated by antiviral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colomba, Giuseppina Maria Elena, Urone, Noemi, Marco, Vito di, Ferraro, Donatella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761199/ https://www.ncbi.nlm.nih.gov/pubmed/33260596 http://dx.doi.org/10.3390/v12121363

Ejemplares similares

Update on the Phylodynamic and Genetic Variability of Marburg Virus
por: Scarpa, Fabio, et al.
Publicado: (2023)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
por: Pellicelli, Adriano M, et al.
Publicado: (2012)

Phylogenetic and Phylodynamic Analyses of HCV Strains Circulating among Patients Using Injectable Drugs in Central Italy
por: Minosse, Claudia, et al.
Publicado: (2021)

Time and Mode of Epidemic HCV-2 Subtypes Spreading in Europe: Phylodynamics in Italy and Albania
por: Ebranati, Erika, et al.
Publicado: (2021)

Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance
por: Calvaruso, Vincenza, et al.
Publicado: (2013)

Viral Phylodynamics
por: Volz, Erik M., et al.
Publicado: (2013)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients
por: Bellocchi, Maria Concetta, et al.
Publicado: (2019)

Update on the Phylodynamics of SADS-CoV
por: Scarpa, Fabio, et al.
Publicado: (2021)

Phylodynamic and Phylogeographic Analysis of Hepatitis Delta Virus Genotype 3 Isolated in South America
por: Nogueira-Lima, Felipe Souza, et al.
Publicado: (2019)

The phylodynamics of the rabies virus in the Russian Federation
por: Deviatkin, Andrei A., et al.
Publicado: (2017)

Phylodynamic analysis in the understanding of the current COVID-19 pandemic and its utility in vaccine and antiviral design and assessment
por: Cardona-Ospina, Jaime A., et al.
Publicado: (2021)

Discovering the Phylodynamics of RNA Viruses
por: Holmes, Edward C., et al.
Publicado: (2009)

Eight challenges in phylodynamic inference
por: Frost, Simon D.W., et al.
Publicado: (2015)

Recent Information on Pan-Genotypic Direct-Acting Antiviral Agents for HCV in Chronic Kidney Disease
por: Fabrizi, Fabrizio, et al.
Publicado: (2022)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations
por: Paolucci, Stefania, et al.
Publicado: (2019)

Tracing the spatiotemporal phylodynamics of Japanese encephalitis virus genotype I throughout Asia and the western Pacific
por: Li, Fan, et al.
Publicado: (2023)

Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples
por: Warkad, Shrikant Dasharath, et al.
Publicado: (2018)

HCV genome-wide analysis for development of efficient culture systems and unravelling of antiviral resistance in genotype 4
por: Pham, Long V., et al.
Publicado: (2022)

Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization
por: Pham, Long V., et al.
Publicado: (2022)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Emergence and Phylodynamics of Citrus tristeza virus in Sicily, Italy
por: Davino, Salvatore, et al.
Publicado: (2013)

Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals
por: Vernuccio, Federica, et al.
Publicado: (2022)

Phylodynamic Inference for Structured Epidemiological Models
por: Rasmussen, David A., et al.
Publicado: (2014)

Phylodynamics of the HIV-1 Epidemic in Cuba
por: Delatorre, Edson, et al.
Publicado: (2013)

Bayesian phylodynamic inference with complex models
por: Volz, Erik M., et al.
Publicado: (2018)

Phylodynamics on local sexual contact networks
por: Rasmussen, David A., et al.
Publicado: (2017)

Phylodynamic Inference across Epidemic Scales
por: Volz, Erik M., et al.
Publicado: (2017)

Model diagnostics and refinement for phylodynamic models
por: Lau, Max S. Y., et al.
Publicado: (2019)

A69 Phylodynamics of language evolution
por: Hoffmann, K, et al.
Publicado: (2019)

Decoding the Fundamental Drivers of Phylodynamic Inference
por: Featherstone, Leo A, et al.
Publicado: (2023)

Characterization of HIV diversity, phylodynamics and drug resistance in Washington, DC
por: Pérez-Losada, Marcos, et al.
Publicado: (2017)

Geographic Distribution of HCV Genotypes and Efficacy of Direct-Acting Antivirals in Chronic HCV-Infected Patients in North and Northeast China: A Real-World Multicenter Study
por: Li, Wencong, et al.
Publicado: (2022)

Antiviral therapy of HCV in the cirrhotic and transplant candidate
por: Herrine, Steven K., et al.
Publicado: (2006)

Antiviral Therapy in HCV-infected Decompensated Cirrhotics
por: Danish, Fazal A., et al.
Publicado: (2010)

Selection dynamics of HCV genotype 3 resistance-associated substitutions under direct-acting antiviral therapy pressure
por: Rodrigues, João Paulo Vilela, et al.
Publicado: (2022)

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
por: Jamalidoust, Marzieh, et al.
Publicado: (2017)

Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland
por: Chlabicz, Slawomir, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7qr5lrec7j1fdtck7cu4jbm6eu